BabA-mediated adherence of pediatric ulcerogenic H. pylori strains to gastric mucins at neutral and acidic pH by Quintana-Hayashi, Macarena P. et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=kvir20
Virulence
ISSN: 2150-5594 (Print) 2150-5608 (Online) Journal homepage: http://www.tandfonline.com/loi/kvir20
BabA-mediated adherence of pediatric ulcerogenic
H. pylori strains to gastric mucins at neutral and
acidic pH
Macarena P. Quintana-Hayashi, Raquel Rocha, Médea Padra, Anders Thorell,
Chunsheng Jin, Niclas G. Karlsson, Mónica Roxo-Rosa, Mónica Oleastro &
Sara K. Lindén
To cite this article: Macarena P. Quintana-Hayashi, Raquel Rocha, Médea Padra, Anders Thorell,
Chunsheng Jin, Niclas G. Karlsson, Mónica Roxo-Rosa, Mónica Oleastro & Sara K. Lindén (2018)
BabA-mediated adherence of pediatric ulcerogenic H.￿pylori strains to gastric mucins at neutral and
acidic pH, Virulence, 9:1, 1699-1717
To link to this article:  https://doi.org/10.1080/21505594.2018.1532243
© 2018 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
View supplementary material 
Accepted author version posted online: 09
Oct 2018.
Published online: 09 Oct 2018.
Submit your article to this journal 
Article views: 180
View Crossmark data
RESEARCH PAPER
BabA-mediated adherence of pediatric ulcerogenic H. pylori strains to gastric
mucins at neutral and acidic pH
Macarena P. Quintana-Hayashia, Raquel Rochab, Médea Padraa, Anders Thorellc, Chunsheng Jina,
Niclas G. Karlssona, Mónica Roxo-Rosa b, Mónica Oleastro d, and Sara K. Lindéna
aDepartment of Biomedical Chemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg,
Gothenburg, Sweden; bDepartment of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal; cDepartment for
Clinical Science and Department of Surgery, Ersta Hospital, Karolinska Institutet, Stockholm, Sweden; dCentro de Estudo de Doenças
Crónicas, Nova Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
ABSTRACT
Helicobacter pylori infection can result in non-ulcer dyspepsia (NUD), peptic ulcer disease (PUD),
adenocarcinoma, and gastric lymphoma. H. pylori reside within the gastric mucus layer, mainly
composed of mucins carrying an array of glycan structures that can serve as bacterial adhesion
epitopes. The aim of the present study was to characterize the binding ability, adhesion modes,
and growth of H. pylori strains from pediatric patients with NUD and PUD to gastric mucins. Our
results showed an increased adhesion capacity of pediatric PUD H. pylori strains to human and
rhesus monkey gastric mucins compared to the NUD strains both at neutral and acidic pH,
regardless if the mucins were positive for Lewis b (Leb), Sialyl-Lewis x (SLex) or LacdiNAc. In
addition to babA positive strains being more common among PUD associated strains, H. pylori
babA positive strains bound more avidly to gastric mucins than NUD babA positive strains at acidic
pH. Binding to Leb was higher among babA positive PUD H. pylori strains compared to NUD strains
at neutral, but not acidic, pH. PUD derived babA-knockout mutants had attenuated binding to
mucins and Leb at acidic and neutral pH, and to SLex and DNA at acidic pH. The results highlight
the role of BabA-mediated adherence of pediatric ulcerogenic H. pylori strains, and points to a role
for BabA in adhesion to charged structures at acidic pH, separate from its specific blood group
binding activity.
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Introduction
In half of the human population, the stomach is colo-
nized by the pathogen Helicobacter pylori (H. pylori). H.
pylori infection generally occurs at an early age result-
ing in a long-term inflammation in the gastric mucosa.
Although infection can be asymptomatic, infected
patients may develop non-ulcer dyspepsia (NUD), pep-
tic ulcer disease (PUD), adenocarcinoma, and mucosa-
associated lymphoid tissue (MALT) lymphoma[1-3].
PUD includes both duodenal ulcer (DU), as a result
of antral infection and acid hypersecretion, and gastric
ulcer (GU) caused by gastric atrophy and acid hypose-
cretion [1].In pediatric patients PUD is rare and occurs
shortly after infection, therefore its pathogenesis is
most likely less dependent on environmental factors
and more importance is given to strain virulence deter-
minants. Genotyping of H. pylori isolates has revealed
certain bacterial genes to be associated with clinical
outcome [4,5]. HomB expression is associated with
PUD in both children and adults, whereas homA is
associated with non-ulcer dyspepsia (NUD) [4,6].
Furthermore, homB has been suggested to play a role
in the inflammatory response and H. pylori adherence
to gastric epithelial cells [4].
The mucus layer that covers mucosal surfaces is
the first barrier that H. pylori encounter, and is the
niche in which most H. pylori are localized. The
mucus layer in the healthy stomach consists mainly
of the gel-forming mucins MUC5AC, secreted from
the superficial mucosa, and MUC6 secreted from the
gland mucosa [7]. In addition to the gel-forming
mucins, the mucus layer also contains the shed extra-
cellular domain of the cell-surface mucin MUC1,
DNA from sloughed off cells, and a range of anti-
microbial molecules [8].
H. pylori uses a range of binding modes to adhere
to the highly glycosylated mucins; via the blood
group antigen binding adhesin (BabA) that binds
to Lewis b (Leb) and related structures, via the sialic
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acid binding adhesin (SabA) that binds to sialyl-
Lewis x (SLex) and sialyl-Lewis a (SLea), and via a
charge/low pH dependent mechanism [9-11].
Furthermore, H. pylori has been suggested to bind
to the GalNAcβ1-4GlcNAc motif (lacdiNAc) via
LabA [12], and both H. pylori and its close relative
H. suis bind to Lacto-N-tetraose (LNT,
Galβ3GlcNAcβ3Galβ4Glc), present on gastric glyco-
lipids and on mucins [13].The adhesion targets and
the glycan environment that H. pylori is exposed to
differ between individuals and become more sialy-
lated in response to H. pylori infection and disease
development [11,14-19]. The presence of the H.
pylori adhesins BabA and SabA hasbeen associated
with a more severe disease outcome. However, in
the H. pylori rhesus macaque infection model, BabA
expression has been shown to decrease within weeks
of infection due to selective pressure, although BabA
was required for establishment of infection [20].
The glycan structures to which H. pylori binds can
be present both on glycolipids and mucins, with the
former most likely conferring a more intimate and
disease promoting adhesion and the latter providing
a decoy and defense system [9,21,22]. Indeed, H.
pylori-infected rhesus monkeys and human children
secreting mucins with lower H. pylori binding ability
develop higher H. pylori density infections and gas-
tritis [19,23]; suggesting that binding of H. pylori to
secreted mucins protects the gastric epithelium.
Gastric mucin turnover is impaired during H. pylori
infection, creating a more stable environment for
long term colonization [24].
To our knowledge, the interactions of H. pylori
strains isolated from children with gastric mucins
remain unknown. Therefore, we characterized the
binding ability and adhesion modes of H. pylori
strains from pediatric patients with NUD and
PUD to human and monkey gastric mucins at
acidic and neutral pH. The mucins were selected
based on their differential display of glycan epitopes
relevant for interactions with H. pylori. Our results
demonstrated increased adherence of PUD H. pylori
strains to gastric mucins compared to the NUD
strains at both neutral and acidic pH. We therefore
investigated the contribution of previously
described H. pylori binding modes (BabA, SabA,
LabA, HomB and the charge dependent mechan-
ism) to this difference in binding. The results high-
light the role of BabA-mediated adherence of
pediatric ulcerogenic H. pylori strains and suggests
a role for BabA in adhesion to charged structures at
acidic pH, separate from its specific blood group
binding activity that has a neutral pH optimum.
Results
Genotypic characterization of NUD and PUD H.
pylori virulence factors
In children peptic ulcer disease occurs shortly after
infection, hence H. pylori virulence determinants
have been suggested to be important in disease devel-
opment [25]. The genetic characterization of H. pylori
clinical isolates has shown an association between
certain bacterial genes (e.g. homB and jhp562) and
the development of PUD in children [4,6,25].
Therefore, the H. pylori strains derived from NUD
(n = 9) and PUD (n = 11) pediatric patients were
genotyped for the presence of putative virulence genes
babA, babB, babC, cagA, vacAs, hopQ allele, oipA,
sabA, hopZ, and homB byWGS (Table 1).The majority
of the PUD strains had a virulence profile character-
ized by the presence of babA (8/11), babB (10/11),
babC (8/11),cagA (11/11), homB (10/11), vacAs1 (10/
11), hopQI (8/11), labA (8/11), and carried the oipA
(10/11) and hopZ (8/11) functional “on” status, while
sabA functional “on” status was not a dominant char-
acteristic (5/11).On the contrary, most NUD H. pylori
strains were negative for babA (7/9), babC (6/9), cagA
(9/9), homB (7/9), had oipA functional status “off” (9/
9), presence of vacAs 2(9/9), labA (9/9), and sabA
functional status “on” (6/9).Overall, the results show
that NUD and PUD H. pylori pediatric strains display
distinct virulence profiles, with PUD strains expressing
several virulence-associated genes such as those encod-
ing the vacuolating cytotoxin VacA, the oncoprotein
CagA, and the outer-membrane proteins (OMPs)
BabA/B, OipA, and HopZ.
At both neutral and acidic pH, PUD H. pylori strains
bind better to mucins than NUD strains
Gastric mucins carry between 40 to100 different glycan
structures resulting in a mucin glycosylation pattern
that differs between individuals and also depends on
health status [26]. We analyzed the binding levels of H.
pylori strains isolated from children with NUD (n=9) or
PUD (n=11), to gastric mucins with and without func-
tional binding sites for the previously published H.
pylori binding modes, BabA, SabA, LabA and the
charge dependent mechanism at acidic pH [9-12]. The
mucins tested were isolated from rhesus monkey nor-
mal gastric mucosa (Leb negative (-), SLex positive (+),
LacdiNAc−), human gastric tumor mucosa (Leb+, SLex+,
LacdiNAc+, sulfate+), and human gastric normal
mucosa (Leb+, SLex-, LacdiNAc+) to provide an array
of glycan structures (Table 2). Since H. pylori can infect
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both humans and monkeys [19], rhesus monkey
mucins also represent a relevant carrier for glycans in
this context.
The adhesion experiments were performed at pH
2.0, pH 4.0, and pH 7.0, representing the pH gradient
found in the gastric mucus layer, with an acidic pH
towards the gastric lumen and a neutral pH towards the
epithelium. The results showed that both NUD and
PUD H. pylori strains bound to human and monkey
mucins independently of their Leb, SLex, LacdiNAc and
acidity (sialic acid) status (Figure 1). Absence of bind-
ing was observed mainly at pH 7: two PUD and seven
NUD strains lacked binding to human mucins, while
seven NUD and one PUD strain did not bind to mon-
key mucins.
Binding of the H. pylori strains isolated from PUD
patients was increased compared to the binding of
NUD strains to all mucins at both acidic and neutral
pH, with higher binding activity at pH 2 than at pH 7
(p≤0.05, Figure 1(a-c)). Based on the strain genotype
(babA, sabA and labA status) and mucin glycosylation,
a similar proportion of the strains are expected to bind
to mucins among the PUD and NUD strains at pH 7: 8/
11 PUD vs 6/9 NUD would theoretically be expected to
bind to the mucin from the human gastric tumor
mucosa (Leb+, SLex+, LacdiNAc+, sulfate+), 9/11 PUD
vs 9/9 NUD to the mucin from the human gastric
normal mucosa (Leb+, SLex-, LacdiNAc+) and 5/11
PUD vs 5/9 NUD to the mucin from the monkey
normal gastric mucosa (Leb-, SLex+, LacdiNAc−,
Table 1. Genotypes/allelic variants of virulence determinants encoding genes of the H. pylori strains included in this study,
determined by whole genome sequencing.
H. pylori Straingenotype Patient
Strain ID Genome accession N° babA2 babB babC cagA oipA sabA hopZ homB vacA labA hopQ Gender Age (yr) Outcome
771/99 SRR6906464 + + + + on on on + (1 copy) s1 + II M 10 DU
417/02 SRR6906463 - + - + on off on + (2 copies) - - I/II M 1 DU
441/02 SRP064603* + + + + on on off - s1# + I F 9 DU
559/02 SRP064604* + + - + on off on + (1 copy) s1 + I M 15 DU
1776/05 SRP064606* + + + + on on off + (1 copy) s1 + I M 15 DU
1089/03 SRP071072* - + + + on off on + (2 copies) s1 - I/II M 10 DU
1152/02 JSUZ00000000** + + + + on off on + (2 copies) s1 - I M 10 DU
1846/05 SRP071062* + - + + on on on + (2 copies) s1 + I M 13 DU
1790/05 SRR6906462 + + + + off on off + (2 copies) s1 + I M 6 DU
1198/04 SRP071060* - + - + on off on + (2 copies) s1 + I M 15 DU
499/02 SRP071064* + + + + on off on + (2 copies) s1 + I M 11 GU
517/99 SRR6906460 - + + - off on on - s2 + II M 14 NUD
892/99 SRR6906466 - + - - off off on - s2 + I F 14 NUD
207/99 SRP071066* - + - - off off off - s2 + I/II F 7 NUD
173/00 SRP071065* - + + - off on on - s2 + II M 14 NUD
655/99 SRP071069* - + - - off on on - s2 + II M 11 NUD
1786/05 JSXW00000000** + + - - off on on - s2 + I/II F 11 NUD
36/00 SRR6906461 - + - - off on off + (1 copy) s2 + I M 9 NUD
565/99 SRR6906459 - + + - off on on + (1 copy) s2 + I M 11 NUD
1500 SRR6906465 + + - - off off on - s2 + I/II F 13 NUD
M, male; F, female; DU, duodenal ulcer; GU, gastric ulcer; NUD, non-ulcer dyspepsia; +, positive for that gene; -, negative for that gene; #, truncated s1 allele; *
[44], ** [45]. The on and off frame status of the genes indicate if the gene is functional or not, respectively.
Table 2. Origin, density, profile and glycan structures of the isolated mucin samples.
Mucinsamples
Density
(g/L) MUC5AC MUC6 MUC2 MUC5B Leb SLex SLea
α1,4-
GlcNAc LacdiNAc*
Acidic
charge*& A# B# H#
Human gastrictumorc 1.39 –
1.43
+ ++ - ++ ++ ++ + - 0.1 9.88 0.91 0 81.46
Human gastricnormalc 1.34 –
1.41
++ + - - ++ - - + 0.78 0 16.09 8.93 25.93
Monkeygastric normale 1.38 –
1.43
+ ++ - - - + + ++ 0.1 1.1 0 47.8 4.4
Human gastric normal
3ISd,e
nd nd nd nd nd + - - - 7.5 10.7 22.4 1.1 60.8
Human gastric normal
4IDd,e
nd - + nd nd - + + + 16.9 16.8 2.9 0 0.4
The relative amount of mucins and glycan structures important for interactions with H. pylori were determined by ELISA and mass spectrometry. The relative
presence or absence of each structure is indicated with ++ (above 75% of the highest assay value), + and – (OD450 less than 0.15 for antibodies giving a
high signal and 0.1 for antibodies giving a low signal). Leb, Lewis b; SLex, sialyl-Lewis x; SLea, sialyl-Lewis a; nd, no data. * Relative abundance (%)
determined by liquid chromatography tandem mass spectrometry. & Relative abundance of charged structures (NeuAc, NeuGc (present in the monkey
normal mucin only), and sulfated structures (present in the human tumor mucin only) on mucins. # Relative abundance of ABH fucosylated antigens. c Data
adapted from Skoog et al. [29], Linden et al. [39], and Jin et al. [26]. d Human gastric normal mucins used in the bacterial growth assays. e The complete list
of identified structures and their relative abundances are available in the supplementary Table S1.
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Table 3). Of the strains expected to bind to the human
gastric tumor mucin 7/8 PUD and 3/6 NUD strains
matched the predicted binding at pH 7. Similarly, 8/9
PUD and 2/9 NUD strains matched the expected bind-
ing to mucins from human gastric normal mucosa at
pH 7. Binding of H. pylori to the monkey mucins was
shown in all five PUD strains expected to bind, and in
2/5 NUD strains at pH 7. Additionally, 1/3 PUD and 3/
3 NUD strains lacking binding to the human tumor
mucins matched the predicted no binding at pH 7. No
matches between non-binding NUD and PUD strains
and predicted no binding to human normal mucin
were observed at pH 7, while four out of four NUD
and one out of six PUD strains matched the predicted
no binding to monkey mucins. Strain genotype can
thus not fully predict binding or binding amplitude to
mucins. This is likely due to related glycans that can act
as ligands for the adhesins in a manner that varies
between strains, and that the topography of the glycans
can result in differences in accessibility between mucins
for binding.
Binding at pH 2 is mainly expected to be conferred
via a charge dependent mechanism [27]. In line with
this, the highest binding avidity was detected to the
mucins from human gastric tumor mucosa followed
by mucins from the monkey normal gastric mucosa
and then the human gastric normal mucosa.
Altogether, the results depict binding properties that
Table 3. Predicted pH where binding is mainly expected based on presence of the BabA, SabA and LabA adhesins in the genome of
the H. pylori strains (Table 1) and glycans known to confer binding identified on the mucins (Table 2).
H. pylori Mucintype and mucin glycans
Strain Patient Human gastrictumor Human gastric normal Monkeygastric normal Human gastric normal 3IS Human gastric normal 4ID
ID outcome (Leb, SLea/x, S) (Leb, LacdiNAc) (SLea/x) (Leb, LacdiNAc) (SLea/x, LacdiNAc)
771/99 PUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
417/02 PUD pH 2 - - - -
441/02 PUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
559/02 PUD pH 2 and 7 pH 7 - pH 7 pH 7
1776/05 PUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
1089/03 PUD pH 2 - - - -
1152/02 PUD pH 2 and 7 pH 7 - pH 7 -
1846/05 PUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
1790/05 PUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
1198/04 PUD pH 2 pH 7 - pH 7 pH 7
499/02 PUD pH 2 and 7 pH 7 - pH 7 pH 7
517/99 NUD pH 2 pH 7 - pH 7 pH 7
892/99 NUD pH 2 pH 7 - pH 7 pH 7
207/99 NUD pH 2 pH 7 - pH 7 pH 7
173/00 NUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
655/99 NUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
1786/05 NUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
36/00 NUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
565/99 NUD pH 2 and 7 pH 7 pH 7 pH 7 pH 7
1500 NUD pH 2 and 7 pH 7 - pH 7 pH 7
Only pH 2 and 7 were included since the pH dependency slope for the binding modes can vary between strains. Although the monkey gastric normal sample
is negative for Leb, it carries other fucosylated structures that have potential for interacting with BabA. However, in the table we only included Leb as BabA
ligand as this is expected to be the main structure conferring binding. Similarly, only the human gastric tumor sample is listed for expected theoretical
interaction with H. pylori at pH 2, as this sample carries sulfated structures in addition to sialylated ones, whereas the other samples carry sialylated
structures whereof only 11% are expected to remain negatively charged at pH2. S, Sulfate; -, absence of known ligand-adhesion interactions; NUD, non-
ulcer dyspepsia; PUD, peptic ulcer disease.
Figure 1. Binding of H. pylori to gastric mucins. Binding of H. pylori strains isolated from children with non-ulcer dyspepsia (NUD,
n=9) or with peptic ulcer disease (PUD, n=11) to mucins isolated from human tumor (A), human normal (B) and monkey normal (C)
gastric tissue. Results are expressed as the median with interquartile range, after subtraction of the background signal (no mucin) at
each pH. Mann-Whitney U test comparing the binding of NUD vs PUD H. pylori strains to mucins at each pH, * p ≤ 0.05, ** p ≤ 0.01.
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differ between NUD and PUD for all mucins at all pHs
(p < 0.05), and that increase in an acidic environment.
Increased binding of gastric mucins to PUD H.
pylori baba positive strains compared to NUD baba
positive strains at acidic pH
BabA and SabA are well studied H. pylori outer mem-
brane proteins that mediate adhesion to the gastric
mucosa, and the babA+ genotype has been associated
with ulcer disease [5]. We characterized the binding
ability of NUD and PUD strains to gastric mucins
according to their babA and sabA status to assess
their role in binding. The babA+ and sabA “on” geno-
types were present in both NUD and PUD H. pylori
strains, with babA+ strains predominantly distributed
within the PUD group (Table 2). At neutral pH, adhe-
sion of babA+ strains was higher than that of babA−
strains and the level of binding of NUD and PUD
babA+ strains to mucins was similar (Figure 2(a-c)).
Thus, differences in binding between NUD and PUD
strains at neutral pH may be largely due to the higher
proportion of babA+ strains in the latter group. At pH 2
however, the PUD babA+ strains displayed higher bind-
ing to mucins isolated from human and monkey nor-
mal gastric tissue compared to NUD babA+ and babA−
strains of both PUD and NUD origin (p = 0.05;
Figure 2(b,c)), indicating the PUD babA has different
adhesion characteristics at acidic pH than NUD babA.
Contrarily, the sabA status does not appear to be a
factor responsible for differences in mucin binding
between PUD and NUD strains, as PUD H. pylori
strains bound more avidly to mucins compared to the
NUD strains regardless of this genotype (Figure 2(d-f)).
Increased leb binding among baba positive PUD H.
pylori strains compared to NUD strains at neutral,
but not acidic ph
In order to elucidate the molecular mechanismmediating
the difference in binding between NUD and PUD H.
pylori strains to mucins, we investigated the five H. pylori
Figure 2. Binding of H. pylori pediatric strains to gastric mucins according to their babA and sabA genotype. A-C) Binding of NUD
and PUD H. pylori babA+ and babA− strains (NUD babA−, n = 7; PUD babA−, n = 3; NUD babA+, n = 2; PUD babA+, n = 8) to mucins
isolated from human tumor (A), human normal (B) and monkey normal (C) gastric tissue. D-F) Binding of NUD and PUD H. pylori
sabA+ and sabA− strains (NUD sabA off, n = 3; PUD sabA off, n = 6; NUD sabA on, n = 6; PUD sabA on, n = 5) to mucins isolated from
human tumor (D), human normal (E) and monkey normal (F) gastric tissue. Results are expressed as minimum, first quartile, median,
third quartile, and maximum in a box and whisker plot, after subtraction of the background signal (no mucin) at each pH. Mann-
Whitney U test comparing binding to mucins of NUD vs PUD strains with the same genotype, * p ≤ 0.05, ** p ≤ 0.01.
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binding modes known to be involved in binding to gastric
mucins (Leb, SLex, LNT, LacdiNAc and charge dependent
binding) at pH 2.0, 4.0, and 7.0. Differences in adhesion
between NUD and PUD H. pylori strains were observed
to the Leb moiety, recognized by the BabA adhesin at
neutral pH (Figure 3(a)). The majority of the babA+
strains had a strong adhesion to Leb (referred to as Leb
high binders) except for the PUD strain 1776/05, which
presented a binding level similar to the NUD and PUD
babA− strains (Leb low binders, Figure 5(a)).
The overall binding to the SLex antigen recog-
nized by SabA, and LNT was of low avidity and no
clear trends were identified regarding pH depen-
dency or differences between NUD and PUD groups
(Figure 3(b-c)). Furthermore, the NUD/PUD origin
and the babA status of the strains were not relevant
in binding to SLex (Figure 5(b)). LacdiNAc carried
by gastric mucins has been described as a target for
H. pylori adherence to the gastric mucosa via the
LabA adhesion [12]. Although the purified monkey
mucin was negative for LacdiNAc and the human
mucins carried the LacdiNAc motif (Table 1), the
binding level among NUD and PUD strains to
mucins was similar, and overall binding level to
mucins was not proportional to the LacdiNAc con-
tent of the mucins (Figure 4, Table 1). Furthermore,
the majority of strains were positive for LabA, and
LabA was present among all NUD strains (Table 2).
Consequently, the results do not suggest a role of
LacdiNAc, SLex or LNT as determinants relevant for
the difference in binding of H. pylori NUD and PUD
strains to gastric mucins.
Binding to DNA was used as a proxy for binding
to charged molecules via the charge/low pH
mechanism (such as sialylation and sulfation present
on mucins), as DNA carries a high density of nega-
tive charge. H.pylori binding to DNA was more
pronounced at acidic than neutral pH, although
similar between NUD and PUD strains (Figure 3
(d)). Surprisingly, PUD babA+ strains with high
Figure 3. Binding of H. pylori to glycoconjugates and DNA. Binding of NUD (n = 9) and PUD (n = 11) H. pylori pediatric strains to Leb
(A), SLex (B), LNT (C), and DNA (D). Results are expressed as minimum, first quartile, median, third quartile, and maximum in a box
and whisker plot, after subtraction of the background signal (no mucin) at each pH. Mann-Whitney U test comparing the binding of
NUD vs PUD H. pylori strains to glycoconjugates and DNA at each pH, * p ≤ 0.05.
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binding ability to Leb bound more to DNA at pH 2
and 7 compared to PUD and NUD babA− strains (p
≤ 0.05, Figure 5(c)).
Attenuated binding of PUD baba-knockout mutants
to mucins and leb at acidic and neutral ph, and to
slex and DNA at acidic pH
To determine the functional role of babA in NUD
and PUD H. pylori adhesion, we analyzed the bind-
ing ability of H. pylori babA-knockout mutant
strains to human and monkey mucins, Leb, SLex,
and DNA compared to their isogenic wild-type
strains (Figure 6). For this, we selected three
babA+ PUD strains, whereof two were Leb high
binders and one was a Leb low binder, and all
three had a low pH dependency in their Leb binding
(i.e. binding to Leb was similar at pH 2 and 7).
Removal of babA reduced the adherence of babA+/
Leb high binding wild-type strains (n = 2) to all
three mucins and to the Leb glycoconjugateat all
pHs (Figure 6(a-d)). An exception to this was that
binding of the sabA and babA positive strain 441/02
to the human tumor mucin (Leb+ and SLex+) at pH
7 instead increased (Figure 6(a)): we have previously
observed that other adhesion modes can gain after
removal of babA [28]. In line with this concept,
there was a trend towards an increase in binding
to SLex too with this strain at pH 7 (Figure 6(e)).
Adhesion of the babA+/Leb low binding strain (n
=1) to human and monkey mucins and to Leb was
attenuated at pH 2 and 4 after knocking out babA,
but the effect was not statistically significant at pH 7
(Figure 6(a-d)). Two out of three babA deletion
mutants exhibited reduced binding to SLex and
DNA at acidic pH compared to their isogenic
wild-type strains (p<0.05), and a similar trend was
observed for the third strain (SLex, p= 0.16 and
Figure 5. Binding of H. pylori strains to glycoconjugates and DNA according to their babA genotype and avidity for Leb. Binding of
NUD and PUD H. pylori strains to Leb (a), SLex (b), and DNA (C). NUD babA− Leb low binder (LB), n = 7; PUD babA− Leb low binder
(LB), n = 3; PUD babA+ Leb low binder (LB), n = 1; NUD babA+ Leb high binder (HB), n = 2; PUD babA+ Leb high binder (HB), n = 7.
Results are expressed as minimum, first quartile, median, third quartile, and maximum in a box and whisker plot. Kruskall-Wallis test
with Dunn’s correction for multiple comparisons, * p ≤ 0.05 and ** p ≤ 0.01 compared to NUD babA− Leb low binder. Mann-Whitney
U test, & p ≤ 0.05 compared to NUD and PUD babA− Leb low binders.
Figure 4. Binding of H. pylori to mucins according to labA genotype. Binding of NUD (n = 9) and PUD (n = 11) H. pylori strains to
mucins isolated from human tumor (a), human normal (b), and monkey normal (c) gastric tissue. Results are expressed as minimum,
first quartile, median, third quartile, and maximum in a box and whisker plot. Kruskall-Wallis test with Dunn’s correction for multiple
comparisons, * p ≤ 0.05 and ** p ≤ 0.01 compared to NUD labA+.
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DNA, p = 0.22, Figure 6(e,f)). This indicates a role
for BabA in charge dependent adhesion at
acidic pH.
No indications that the homB, oipA, and cagA
virulence genes play a role in the differential
binding of NUD and PUD strains to mucins,
synthetic glycoconjugates and DNA
HomB positive (+) H. pylori clinical isolates have been
associated with PUD in children [4], and in line with this
study the proportion of homB+ strains was higher among
the H. pylori PUD than NUD strains (Table 1). HomB+
strains have been suggested to bind better to a human
gastric epithelial cancer cell line (AGS) than homB−
strains [4]. However, there was no association between
the homBgenotype of the NUD and PUDH. pylori strains
and binding to mucins, Leb, SLex, or LNT
glycoconjugates, or DNA (marker for acidic charge) at
any of the pH tested, and binding varied between strains
(Figure 7(a-c)). Furthermore, adhesion of the homB-
knockout mutant strains to mucins, glycoconjugates
and DNA was not different from their isogenic wild-
type strains (Figure 8(a-g)), except lower binding of the
PUD homB-knockout mutants to the human gastric
tumor mucin at pH 2 (p = 0.02, Figure 8(a)). In a similar
manner, there was no clear trend in binding of the NUD
and PUD H. pylori strains to mucins according to their
oipA genotype (data not shown). As a result of all PUD
strains being cagA+ and all NUD strains cagA− (Table 1),
binding to mucins of PUD cagA+ H. pylori strains was
higher than the NUD group at all pH (data not shown).
However, the cagA gene product plays a role after bacter-
ial attachment to gastric epithelial cells and is injected
into cells via the type IV secretion system; therefore, a
causal association between this genotype and binding to
Figure 6. Binding of NUD and PUD H. pylori wild type and isogenic babA-knockout mutant strains to mucins isolated from human
tumor (A), human normal (B) and monkey normal (C) gastric tissue, Leb (D), SLex (E), and DNA (F). Data is grouped according to strain
babA status and binding ability to Leb: PUD babA+ Leb high binder WT (n = 2, 559/02 and 441/02), PUD Leb high binder isogenic
babA_KO (n = 2, 559/02 and 441/02 babA_KO), PUD babA+ Leb low binder WT (n = 1, 1776/05), and PUD Leb low binder isogenic
babA_KO (n = 1, 1776/05 babA_KO). Results are expressed as the mean of technical replicates ± SEM, after subtraction of the
background signal (no mucin) at each pH. Student’s t-test comparing the binding of the WT strain vs their respective isogenic babA
KO strain, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001.
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Figure 7. Binding of H. pylori to mucins grouped according to their homB genotype. Binding of H. pylori strains isolated from
children with non-ulcer dyspepsia (NUD, n = 9) or with peptic ulcer disease (PUD, n = 11) to mucins isolated from human tumor (A),
human normal (B) and monkey normal (C) gastric tissue according to their homB status. Results are expressed as the average of
technical replicates ± SEM, after subtraction of the background signal (no mucin) at each pH. Overall One-way ANOVA comparing
the binding of H. pylori strains to mucins within each group (* p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001), demonstrating that statistically
significant differences are present between the strains within each group,e.g. within NUD homB−. However, there are no differences
between NUD and PUD derived strains.
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gastric mucins is unlikely. Overall, no major effects of
homB and oipA genotypes on H. pylori adhesion to
mucins were identified.
The lebcarrying mucin and leb glycoconjugate
inhibit growth of PUD H. pylori babA positive
strains at ph 5 and 7, whereas the ɑ1,4-GlcNAc
positive mucin has an inhibitory effect on both
NUD and PUD strains
Mucins can have an inhibitory or stimulatory effect
on H. pylori proliferation mainly depending on
mucin glycosylation and binding ability [29]. As
differences were observed in adhesion of NUD and
PUD strains to mucins and Leb we studied the effect
of purified gastric mucinsand the Leb glycoconjugate
on H. pylori proliferation. The assays were per-
formed at pH 7 and 5. Two NUD H. pylori strains
(36/00 and 565/99) both babA− and low Leb binders,
and two babA+ PUD strains (559/02 and 1846/05)
with high binding ability to Leb were co-cultured
separately with two differentially glycosylated
human gastric mucins (Leb+/ɑ1,4-GlcNAc−and Leb-/
ɑ1,4-GlcNAc+) and the Leb glycoconjugate. The
reducing potential of viable cells was measured
over time by a luciferase based kit in which the
luminescent signal is proportional to the number
of viable cells in culture. Similarly to a report on
the inhibitory effect of Leb on H. pylori proliferation
at neutral pH [28], our results show growth inhibi-
tion of the PUD babA+ H. pylori strains in response
to the Leb glycoconjugate and Leb positive mucin at
pH 7 and 5 (p ≤ 0.01, Figure 9(a,b)). The Leb
glycoconjugate and Leb carrying mucin had no
effect on the proliferation of NUD babA− strains
(Figure 9(a,b)), suggesting that the inhibitory effect
of Leb on H. pylori is BabA dependent. Previous
studies have demonstrated antimicrobial activity of
mucins carrying terminal ɑ1,4-GlcNAc [28,30], and
in line with this, a mucin carrying ɑ1,4-GlcNAc
inhibited growth of both NUD and PUD H. pylori
strains regardless of pH (p ≤ 0.01, Figure 9(a,b)).
Discussion
In this study, we characterized the binding ability and
adhesion modes of H. pylori strains isolated from
pediatric patients with NUD and PUD to gastric
mucins at acidic and neutral pH. Our results showed
that pediatric H. pylori strains isolated from children
with PUD display an increased binding activity to gas-
tric mucins at both neutral and acidic pH compared to
NUD strains. The PUD H. pylori babA positive geno-
type was associated with increased adhesion to Leb at
neutral pH and via the charge dependent binding mode
at acidic pH, suggesting a role for BabA separate from
its specific blood group binding activity. Furthermore,
the reduced adherence of PUD babA-knockout mutants
Figure 8. Binding of H. pylori wild-type and isogenic homB-knockout mutant strains to mucins, glycoconjugates, and DNA. Binding of
H. pylori wild-type (WT) strains isolated from children with non-ulcer dyspepsia (NUD, n = 2) or with peptic ulcer disease (PUD, n = 5)
and their isogenic homB-knockout (KO) mutant strains to mucins isolated from human tumor (A), human normal (B) and monkey
normal (C) gastric tissue, to Leb (D), LNT (E), and SLex (F) glycoconjugates, and to DNA (G). Results are expressed as the median with
interquartile range, after subtraction of the background signal (no mucin) at each pH. Mann-Whitney U test comparing the binding
of the WT strain vs their respective isogenic homB KO strain, * p ≤ 0.05.
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to mucins, DNA and Leb indicate a functional role of
BabA in the adherence of pediatric ulcerogenic strains
both under neutral and acidic conditions.
H. pylori colonization of the stomach generally
occurs during early childhood [31]. Although gastric
ulcers seldom occur in the pediatric population, when
present, they develop shortly after infection [25].
Studies have pointed at enhanced virulence features
among H. pylori ulcerogenic strains isolated from chil-
dren compared to non-ulcerogenic strains, resulting in
impairment of gastric cell viability with cytoskeletal
damage accompanied by decreased intracellular mucin
content in vitro [25]. Ulcerogenic pediatric strains share
a similar proteome profile and several putative viru-
lence genes, such as cagA, vacAs1, oipA on status, homB
and jhp562, have been related with ulcer disease in
children [4,6,25,32,33]. It has been suggested that the
pediatric H. pylori strains carrying the triple genotype
cagA, jhp562, and homBare clinically relevant in PUD
outcome [33]. In our study, nearly all PUD strains
carried the vacAs1, cagA, oipA on status and homB
genes, contrary to the virulence profile of the NUD
strains. However, there were no indications that the
aforementioned genes play a biological role in the
differential adhesion of pediatric ulcerogenic strains to
gastric mucins. The clinical relevance of H. pylori adhe-
sins, such as BabA2, and Lewis antigens in the patho-
genesis of ulcer disease has been reported [5]. The
BabA2 genotype was predominant among the screened
pediatric H. pylori PUD strains; furthermore, the babA2
positive ulcerogenic strains concomitantly displayed
increased adhesion ability to gastric mucins, pointing
towards the biological relevance of babA in gastric
colonization and pediatric ulcer disease development.
Bacterial adherence to secreted mucins depends both
on the host’s mucin glycosylation and on adhesins
expressed by the bacteria. Gastric mucins carry a diver-
sity of carbohydrate structures, some of which serve as
binding sites for H. pylori. Mucin expression and gly-
cosylation (Lea, Leb, Lex, SLex and SLea) has been
shown to be similar in the stomach of uninfected chil-
dren and adults [23]. In an American cohort, pediatric
H. pylori infection was not associated with ectopic
MUC6 or MUC2 expression [23],whereas MUC2 anti-
body reactivity increased with age among pediatric
samples in an Asian cohort [34]. Tissue sections from
H. pylori infected pediatric patients contain a lower
proportion of mucus producing cells than non-infected
Figure 9. H. pylori proliferation in the presence of mucins and Leb. Effect of gastric mucins and Leb on the growth of NUD and PUD
H. pylori pediatric strains at pH 5 (A) and 7 (B). Results are expressed as the mean percent difference of the luminescent signal
compared to the proliferation control ± SEM. One-Way ANOVA with Dunnett’s correction for multiple comparisons, ** p ≤ 0.01, ****
p ≤ 0.0001.
VIRULENCE 1709
tissues due to infiltrating immune cells, and the tall
epithelial cells loaded with mucus are often shorter/
flatter with less mucus in the mucin thecae during
infection [23]. This is likely the reason why the propor-
tion of the tissue that stained positive for MUC5AC
was lower in infected pediatric samples [34]. Gastric
mucins secreted from the superficial mucosa can pre-
vent H. pylori binding to the epithelial surface [21].
Similar to rhesus monkeys, Leb positive children had a
lower H. pylori density than Leb negative children,
highlighting a role of secretor and Lewis status in
resistance to infection [19,23]. However, among chil-
dren with PUD, the proportion that are Leb positive is
similar to that of the general population [23]. Mucin
glycosylation can also affect H. pylori expression of
virulence genes and growth by either having a prolif-
erative or inhibitory effect [28,29]. H. pylori BabA
dependent binding to human gastric mucins has been
shown to inhibit proliferation due to bacterial aggrega-
tion and mucins carrying the ɑ1,4-GlcNAc terminal
structure have antimicrobial activity [28,30]. Similarly,
gastric mucins decorated with Leb as well as the syn-
thetic Leb structure repressed the growth of babA posi-
tive strains and mucins carrying ɑ1,4-GlcNAc repressed
growth of all strains regardless of NUD/PUD origin
and babA status.
To our knowledge, there are no previous reports
on the binding ability and adhesion modes of H.
pylori strains isolated from children to gastric mucins.
Since the gastric mucus layer provides an acidic to
neutral pH gradient, we considered relevant to study
the effect of pH on pediatric H. pylori adhesion to
mucins. Our observations showed that both at neutral
and acidic pH H. pylori PUD strains had the intrinsic
ability to bind better to all mucins compared to the
NUD strains, with enhanced binding properties in
acidic conditions. In addition to that a high propor-
tion of PUD strains are positive for babA, the increase
in binding at acidic pH was associated to babA
expression, as PUD H. pylori babA+ strains bound
considerably more to gastric mucins than NUD
babA± strains. Although the pH optimum in binding
to Leb was at pH 7 in line with published studies
showing that the specific blood group binding activity
of BabA has a neutral pH optimum [27,35], mucin
binding at neutral pH was considerably lower than
that observed at acidic pH. Adhesion at acidic pH was
twice as high to the mucins that carried charged
structures (such as SLex) compared to the mucins
lacking SLex, but this effect was not dependent on
the presence of SabA. BabA from different strains
have been shown to vary in which fucosylated blood
group related structures they preferentially bind to,
both to individual structures and when present on
mucins [9,10]. Furthermore, BabA differ in pH sensi-
tivity among strains, with strains isolated from corpus
loosing Leb binding activity at a lower pH than strains
isolated from antrum [35]. In line with these results,
high binding level to mucins remained at acidic pH
among the PUD strains: for some strains BabA
dependent binding to Leb remained high whereas for
others BabA dependent binding to charged glycan
structures was a prominent feature. Peptic ulcers are
associated with a more acidic pH [36], suggesting that
the pathogen adapts to a more acidic environment.
Hence, at both acidic and neutral pH pediatric ulcero-
genic babA+ strains displayed adhesion properties dis-
tinct from non-ulcerogenic strains. The functionality
of babA was further supported by loss in adherence to
mucins and Leb after removal of babA at both acidic
and neutral pH. Additionally, at acidic pH removal of
babA decreased H. pylori binding to SLex and DNA in
two out of three strains, suggesting that babA can be
involved in charge dependent adhesion.
Although PUD strains had a higher level of bind-
ing to mucins than NUD strains, we do not believe
that having mucins that bind to pathogens is negative
to the host. On the contrary, both rhesus monkeys
and children that produce mucins that bind well to
H. pylori have lower gastritis and pathogen burden in
their stomachs [19,23]. Furthermore, mice lacking the
Muc1 mucin are more susceptible to infection by H.
pylori [37]. The pathogenicity decreasing effect of
mucins is likely due to a combination of mucins
binding and disseminating the pathogen and by that
mucin binding can decrease the growth of the patho-
gen [19,28]. Mucins can carry similar glyco-epitopes
as glycolipids, and act as a decoy for the intimate
adherence conferred by Helicobacter adhesion to gly-
colipids in the gastric epithelium [9,21].The higher
binding of PUD strains to mucins shown here, most
likely reflects a higher avidity for fucosylated and
sialylated glycolipid targets on the epithelial cell sur-
face. Although the pH at the epithelial surface is close
to neutral under healthy conditions, increased acid
production or damaged mucus layer has potential to
decrease the pH at the epithelial surface. Thus, the
higher binding to mucins by PUD strains in combi-
nation with previous studies demonstrating a host
protective role for mucin binding [19,21,23,38], sug-
gest that PUD strains have a higher fitness for bind-
ing to the host although the host also produces
binding decoys on mucins and mucin-bound bacteria
are removed and disseminated with the shedding of
the mucus (Figure 10).
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In conclusion, H. pylori isolated from pediatric
patients with PUD bind to mucins with higher avid-
ity at both acidic and neutral pH than those isolated
from children with NUD. This higher avidity is
caused by a combination of higher prevalence of
BabA and BabA binding to charged structures (i.e.
sulfated and sialic acid containing structures) at
acidic pH.
Materials and methods
Ethics
Three human samples were collected after informed writ-
ten consent and in accordance with approval of the local
ethics committee (Lund University Hospital, Lund, and
Regionalaetikprövningsnämnden I Göteborg, Sweden).
The fourth specimen was from a tumor sample from
our well characterized mucin library, collected in 1983
at the IMIM-Hospital del Mar, Barcelona, Spain (before
the hospital had an ethics committee). The rhesus mon-
key samples were also from ourmucin library, collected in
conjunction with a previous study [39]. These samples
were collected in accordance with approval of the
Uniformed Services University of the Health Sciences
animal care and use committee, USA).
Isolation of mucins
The main part of the study was performed on mucins
isolated from two human gastric specimens and one
rhesus monkey gastric tissue. One human specimen was
from a gastric adenocarcinoma tumor (intestinal type,
hereafter referred to as human tumor sample) and the
other one from macroscopically normal antral mucosa of
a tumor-affected stomach (hereafter referred to as human
normal sample), as evaluated by a clinical pathologist. The
rhesus monkey sample was positive for H. suis but was
otherwise normal (gastritis score < 1 according to the
Sydney system) [39]. The isolated human mucins have
been previously characterized in detail [26,29,39].We also
screened three rhesus monkeys gastric mucins from our
archived mucin library using mass spectrometry (results
in supplementary table S1) and selected one negative for
Leb and lacdiNAc to complement the glycan repertoir of
the human mucins [26]. Additionally, two mucins (3IS:
Leb positive/ɑ1,4-GlcNAc negative, and 4ID: Leb nega-
tive/ɑ1,4-GlcNAc positive) were isolated from human
normal gastric tissue obtained from obese patients under-
going bariatric surgery and were used in bacterial prolif-
eration assays. The mucins were isolated from tissue
specimens after rinsing with phosphate-buffered saline
(0.15 M NaCl, 5 mM sodium phosphate buffer, pH 7.4).
Frozen tissue pieces were drenched in 10 mM sodium
phosphate buffer (pH 6.5) containing 0.1 mM phenyl-
methylsulphonylfluorid (PMSF). The surface and sub-
mucosa of normal tissue was removed by scraping the
tissue with a glass microscope slide. Tumor tissue was
homogenized without prior scraping. The material was
immersed in liquid nitrogen and pulverized in a Retch
tissue pulverizer (Retch GmBH& Co., Haan, Germany),
Figure 10. Consequences of H. pylori binding to secreted mucins, membrane bound mucins and glycolipids. Depending on the
genotype of the infecting strain as well as the glycans expressed by the host (depends on inflammatory status and host genotype),
H. pylori can bind to glycans on glycosphingolipids, membrane-bound mucins and secreted mucins at neutral pH close to the
epithelial cells as well as to mucins in the mucus layer or lumen at acidic pH. The mucins constantly flow away from the epithelial
surface, are shed into the lumen and removed from the stomach with the gastric emptying. Please note that components in the
figure are not drawn to scale: i.e. in the body, the mucus layer is thicker and H. pylori smaller compared to other components in the
figure.
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then placed into five volumes of extraction buffer (6 M
guanidinium chloride, 5mM ethylenediaminetetraacetic
acid (EDTA), 10 mM sodium phosphate buffer, pH 6.5)
containing 0.1 mM PMSF and dispersed using a Dounce
homogenizer (four strokes with a loose pestle) and stirred
slowly at 4°C overnight. The insoluble material was
removed by centrifugation at 23,000 × g for 50 min at 4°
C (Beckman JA-30 rotor). Supernatants were dialyzed
against ten volumes of extraction buffer for 24 h and
then filled up to 26 mL with extraction buffer. Cesium
chloride was added to the samples to give 1.39 g/mL
starting density by gentle stirring. The samples were cen-
trifuged at 40,000 × g for 90 h at 15°C. The fractions were
collected from the bottom of the tubes with a fraction
collector equipped with a drop counter. Density measure-
ments were performed using a Carlsberg pipette as a
pycnometer. UV light absorbance at 280 nm demon-
strated that DNA and low density proteins were in other
fractions than the high density mucins. The glycan struc-
tures on these mucins are also available in the supplemen-
tary table S1.
Detection of carbohydrates as a measure of mucin
concentration
Density gradient fractions of purified mucin samples
were analyzed for carbohydrates as periodate-oxidizable
structures in a microtiter-based assay. Polysorp 96-well
plates (ThermoFisher Scientific, 475094) were coated
with mucin sample and kept overnight at 4°C. After
washing three times with a washing solution (5mM
Tris-HCl, 0.15 M NaCl, 0.005% Tween 20, 0.02%
NaN3, pH 7.75), the carbohydrates were oxidized by
treatment with 25 mM sodium metaperiodate in 0.1 M
sodium acetate buffer, pH 5.5 for 20 min at room
temperature (RT). The plates were washed again and
the wells were blocked with DELFIA (dissociation-
enhanced lanthanide fluoroimmunoassay) blocking
solution (50 mMTris-HCl, 0.15 M NaCl, 90 µM
CaCl2, 4 µM EDTA, 0.02% NaN3, 6% sorbitol, 0.1%
bovine serum albumin (BSA), pH 7.75) for 1 h. After
further washing, the samples were incubated for 1 h
with 2.5 µM biotin hydrazide in 0.1 M sodium acetate
buffer, pH 5.5, followed by washing. Europium-labeled
streptavidin was diluted 1/400 in assay buffer (50
mMTris-HCl, 0.15 M NaCl, 20 µM diethylenetriamine-
pentaacetic acid, 0.01% Tween 20, 0.02% NaN3, 1.5%
BSA, pH 7.75) and was added to the wells. After 1 h
incubation, the plates were washed six times and then
incubated with enhancement solution (0.05 M NaOH,
0.1 M phthalate, 0.1% Triton X-100, 50 µM tri-n-octyl-
phosphine oxide, 15 µM β-2-naphthoyltrifluoroace-
tone) for 5 min on a shaker. Fluorescence was
measured (λex=340 nm and λem=615 nm) using a
Wallac 1420 VICTOR2 plate reader with the
Europium label protocol (PerkinElmer, Waltham, MA,
USA). Gradient fractions containing mucins were
pooled together. Mucin concentration in pooled sam-
ples was determined by the same method including a
standard curve of a fusion protein of MUC1, 16TR and
IgG2a Fc starting at a concentration of 20 µg/mL using
seven 1/2 serial dilutions. Pooled samples were dialysed
(cellulose membrane, molecular weight cut-off 14 kDa
Sigma-Aldrich, St. Louise, MO, USA) against sterile
PBS prior to use in bacterial cultures.
Enzyme-linked immunosorbent assays for glycan
and mucin determination
Mucin samples were analyzed for the relative content
of Leb, SLea, SLex, α1,4-GlcNAc, MUC5AC, MUC6,
MUC2 and MUC5B. The mucin samples were diluted
in 4 M GuHCl to 6 µg/mL for the glycosylation
analysis or to 3 µg/mL for the mucin analysis and
coated in 96-well Polysorp plates overnight at 4°C.
The samples analyzed with LUM6-3, LUM2-3 and
LUM5B-2 were reduced with 2 mM 1,4-dithiothreitol
in 6 M GuHCl, 5 mM EDTA, 0.1 M Tris-HCl buffer,
pH 8.0, at 37°C for 1 h and alkylated in 5 mM
iodoacetamide at RT for 1 h in the dark to expose
the epitopes. All plates were washed three times with
PBS 0.05% Tween (washing buffer) and the wells
were blocked for 1 h with Blocking Reagent for
ELISA (Roche, 11112589001) containing 0.05%
Tween (blocking buffer) at RT. After discarding the
blocking buffer, the plates were incubated for 1 h
with Seraclone anti-Leb (Biotest, clone LE2), anti-
sialyl-Lea (NeoMarkers, clone CA19-9), anti-sialyl-
Lex (AM3, courtesy of Dr. C. Hanski, University
Medical Center Charité, Berlin, Germany) diluted to
1 mg/mL, 1/200, 1/1000 and 1/20, respectively, and
anti-α1,4-GlcNAc (Kanto Chemical Co., Inc.,
HIK1083) diluted 1/50, anti-MUC5AC (Sigma-
Aldrich, 45M1) diluted 1/8000, anti-MUC6 (LUM6-
3) [40], anti-MUC2 (LUM2-3) [41], and anti-MUC5B
(LUM5B-2) [42] diluted 1/2000 in blocking buffer.
The plates were washed three times and then incu-
bated for 1 h with 0.8 µg/mL horseradish peroxidase
(HRP) conjugated anti-mouse IgM, anti-mouse IgG
or anti-rabbit IgG diluted in blocking buffer. After
washing, 100 µL tetramethylbenzidine (TMB) sub-
strate (Sigma-Aldrich, T0440) was added to the
wells and the plates were monitored for color devel-
opment. The reaction was stopped with an equivalent
amount of 0.5 M H2SO4 and the absorbance at 450
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nm was measured. The mucin density, profile, and
glycan structures are summarized in Table 2.
Mucin glycan identification by mass spectrometry
O-glycans were released and analyzed as described pre-
viously [26]. In brief, O-glycans were released by reduc-
tive β-elimination. Released glycans were analyzed by
LC-MS using a 10 cm × 250 μm I.D. column, prepared
in-house, containing 5 μm porous graphitized carbon
particles (Thermo Scientific, Waltham, MA, USA).
Glycans were eluted using a linear gradient from
0–40% acetonitrile in 10 mM NH4HCO3 over 40 min
at a flow rate of 10 μL/min. The eluted glycans were
detected using a LTQ ion trap mass spectrometer
(Thermo Scientific) in negative ion mode with an elec-
tro spray voltage of 3.5 kV, a capillary voltage of −33.0
V, and a capillary temperature of 300°C. Air was used
as sheath gas and mass ranges were defined dependent
on the specific structure to be analyzed. The data were
processed using the X calibur software (version 2.0.7,
Thermo Scientific). Glycans were identified from their
MS/MS spectra by manual annotation. Diagnostic frag-
mentation ions for O-glycans were investigated as
described [43]. The annotated structures and associated
MIRAGE (the Minimum Information Required for a
Glycomics Experiment) are available at the UniCarb-
DR database (http://unicarb-dr.biomedicine.gu.se/refer
ences/348).
Helicobacter pylori clinical strains
Twenty H. pylori strains were isolated from biopsies
obtained from Portuguese children aged 1 to 15 years.
Nine H. pylori strains were collected from patients with
abdominal pain and gastritis (non-ulcer dyspepsia,
NUD), and the remaining 11 strains were isolated
from children with gastric or duodenal ulcers (PUD).
Patient data and H. pylori strains included in this study
are presented in Table 1.
Genotyping of H. pylori virulence genes
All of the NUD and PUD H. pylori pediatric strains
were genotyped for the presence/status of babA, babB,
babC, cagA, vacAsallele, hopQ allele, oipA, sabA, hopZ,
and homB outer membrane protein encoding genes
(Table 1) by whole genome sequencing (WGS), con-
sidering the previously published 12 H. pylori genomes
[44,45], and eight new genomes, that were sequenced
on a MiSeq Illumina platform, as previously described
[45]. Briefly, high-quality genomic DNA samples from
pure bacterial cultures were used to prepare Nextera
XT Illumina libraries that were sequenced on an
Illumina MiSeq platform (Illumina Inc., San Diego,
CA) using the v.2 (300 cycles, 2×150 nt reads or 500
cycles, 2×250 nt reads) kit, according to the manufac-
turer’s instructions. FastQC v0.11.3 (http://www.bioin
formatics.babraham.ac.uk/projects/fastqc/) and FASTX
v0.0.13 (http://hannonlab.cshl.edu/fastx_toolkit/) soft-
ware tools were applied to evaluate and improve the
quality of the raw read sequence data, respectively.
Draft genomes were de novo assembled using SPAdes
v3.7.1. The Rapid Annotation using Subsystem
Technology (RAST) server was used for annotation of
the whole-genome in order to identify presence/status
of the previously described virulence genes [46]. Raw
sequence reads of the genomes of H. pylori strains have
been deposited in the Sequence Read Archive (SRA)
(accession numbers are provided in Table 1).
Construction of H. pylori babA and homB knockout
mutant strains
The homB and babA knockout mutant strains were
constructed by insertion of a kanamycin cassette by
natural transformation and double homologous recom-
bination, as previously described [4]. Seven H. pylori
clinical strains were used for homB knockouts, two
NUD strains (565/99, 36/00) and five DU strains
(417/02, 1089/03, 771/99, 559/02 and 1776/05), while
for babA knockout three DU strains were used (559/02,
1776/05, 441/02).The correct and unique insertion of
the antibiotic cassette was confirmed by NGS for two
babA mutant strains (1776/05 and 441/02), as described
above, and by Southern-blot for the remaining mutants,
as previously described [4].
Bacterial culture conditions
H. pylori strains were cultured on Brucella medium
base (Oxoid, CM0169B) supplemented with 10%
bovine blood, 1% Vitox supplement (Oxoid,
SR0090H), 4 mg/L Amphotericin B, 10 mg/L
Vancomycin and 5 mg/L Trimethoprim in a microaer-
ophilic environment (5% O2 and 15% CO2) at 37°C.
Binding of H. pylori to mucins and glycoconjugates
Human and monkey gastric mucin samples, DNA, and
carbohydrate structures Leb, SLex, and Lactose-N-tetra-
ose (LNT) conjugated to human serum albumin
(IsoSep AB, 61/08, 61/66, and 60/97 respectively),
were diluted to 4 µg/mL and coated overnight at 4°C
onto Polysorp96-well plates. The plates were washed
three times with PBS containing 0.05% Tween and
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blocked for 1 h with 1% blocking reagent for ELISA
(Roche, 11112589001). After discarding the blocking
buffer, bacteria with an OD600 of 0.1 were diluted 1/
10 in a solution containing 1% blocking reagent for
ELISA (1% protein w/v in 50mM Tris-HCl and 150
mMNaCl), 0.05% Tween, and 10 mM citric acid, set
to pH 2.0, 4.0 and 7.0. Changing the pH from 7.0 to 2.0
changes the osmolarity of the solution by aproximately
0.25%. A 100 µL of bacterial suspension were added to
the plates, and incubated at 37°C for 2 h with shaking.
The plates were washed three times with PBS, followed
by incubation with a rabbit anti-H. pylori serum (kindly
provided by Thomas Bóren, Umeå University) diluted
1/1000 for 1 h at RT. Three more washes with PBS
containing 0.05% Tween were performed before and
after wells were incubated with a horse radish perox-
idase (HRP) conjugated donkey anti-rabbit IgG
(Jackson ImmunoResearch, West Grove, PA, USA)
diluted 1/10000 for 1 h. Subsequently, 100µL of tetra-
methylbenzidine substrate (Sigma-Aldrich, T0440) was
added per well, and the reaction was stopped with an
equivalent volume of 0.5 M H2SO4. Absorbance at 450
nm was measured in a Wallac 1420 VICTOR2 plate
reader.
H. pylori proliferation in co-culture with mucins and
leb
H. pylori were harvested from agar plates into PBS,
centrifuged at 2500 g for 5 min, and resuspended in
Brucella broth containing 10 mM urea and 20% FBS to
an OD600 of 0.1. The bacterial suspension and dialyzed
human mucins (3IS: Leb+/ɑ1,4-GlcNAc−, and 4ID: Leb-/
ɑ1,4-GlcNAc+) or Leb (IsoSep AB) diluted in PBS
(100 µg/mL), were added to a volume of 100 µL per
well in a 96-well plate. Proliferation control wells con-
tained PBS instead of mucins in addition to the culture
medium. To ensure residual CsCl and GuHCl had no
adverse effects on H. pylori growth, a control consisting
of CsCl dissolved in 4 M GuHCl was dialyzed in par-
allel to the mucins, and had similar results on H. pylori
growth compared to the PBS control. The plate was
covered and incubated at 37°C in a microaerophilic
environment for 4 h. One hundred microliters of the
RealTime-Glo cell viability assay (Promega, G9712)
diluted 1/500 in Brucella broth containing 10 mM
urea and 20% FBS were added per well, resulting in a
final OD600 of 0.05 and final volume of 200 µL. The
assay was performed at pH 5 and 7. The microtiter
plate was covered with a sterile gas permeable sealing
membrane (Diversified Biotech) and incubated at 37°C
inside a plate reader (CLARIOstar, BGM labtech
GmbH, Ortenberg, Germany) connected to an
atmospheric unit set to 5% O2 and 10% CO2 for 24 h.
Luminescence readings were measured every 2 h for
24 h.
Statistics
Statistical analysis was performed using GraphPad
Prism version 6 software (La Jolla, CA, USA). Results
are expressed as the mean ± standard errors of the
means (SEM) for normally distributed data, and med-
ian with interquartile range (IQR) for data that did not
follow a normal distribution (determined using the
D’Agostino-Pearson omnibus test). Data were analyzed
using the Student’s t, Mann-Whitney U, Kruskal-Wallis
or One-way ANOVA tests wherever applicable, and p
values ≤ 0.05 were considered as statistically significant.
Abbreviations
NUD Non-ulcer dyspepsia
PUD Peptic ulcer disease
Leb Lewis b
SLex Sialyl-Lewis x
SLea Sialyl-Lewis a
LNT Lacto-N-tetraose
LacdiNAc GalNAcβ1-4GlcNAc
H. pylori Helicobacter pylori
H. suis Helicobacter suis
MALT Mucosa-associated lymphoid tissue
DU Duodenal ulcer
GU Gastric ulcer
SabA Sialic acid binding adhesin
BabA Blood group antigen binding adhesin
cagA Cytotoxin-associated gene A
vacA Vacuolating cytotoxin gene A
hopQ Helicobacter pylori outer membrane protein Q
oipA Outer inflammatory protein A
hopZ Helicobacter pylori outer membrane protein Z
homB Helicobacter pylori outer membrane adhesion
molecule B
WGS Whole genome shotgun
OMPs Outer membrane proteins
IS Insoluble surface
ID Insoluble deep
EDTA Ethylenediaminetetraacetic acid
PMSF Phenylmethylsulfonyl fluoride
DELFIA Dissociation-enhanced lanthanide fluoroim
munoassay
BSA Bovine serum albumin
ELISA Enzyme-linked immunosorbent assay
TMB 3,3′,5,5′-Tetramethylbenzidine
RAST Rapid Annotation using Subsystem Technology
SRA Sequence Read Archive
LC-MS Liquid chromatography–mass spectrometry
HRP Horseradish peroxidase
CsCl Cesium chloride
GuHCl Guanidinium hydrochloride
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